AssetMark’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
Other funds holding PJP
MWM
AssetMark's PJP Position: Q1 2025 in Review
AssetMark sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2025, closing a stake of 21 shares — an estimated $1.74K sold.
AssetMark first reported a position in PJP in Q3 2013 and held it in 11 quarters. The position peaked at $2.21M in Q3 2013. 96 funds tracked by Wall St. Rank hold PJP as of Q1 2025.
- AssetMark reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
- AssetMark sold 21 Invesco Pharmaceuticals ETF shares in Q1 2025, an estimated $1.74K.
- AssetMark first reported a position in Invesco Pharmaceuticals ETF in Q3 2013 and held it in 11 quarters.
- AssetMark's Invesco Pharmaceuticals ETF position peaked at $2.21M in Q3 2013.
- 96 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2025.
Based on AssetMark's 13F filing for Q1 2025, filed 6 May 2025.